Skip to content

effect of statin on pain course

Effect of rosuvastatine on lumbar radicular pain: a double blind, placebo control clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170828035960N4
Enrollment
90
Registered
2020-09-06
Start date
2020-07-22
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar chronic pain. Low back pain

Interventions

Intervention 1: Intervention group: participants receive analgesics+"pregabaline". previous analgesics will be continued as before. Pregabaline ( Actoverco company) 75 mg/day administered orally. Inte

Sponsors

Saveh University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Lumbosacral pain with radiation to below the knee, and irrespective of the aetiology (tumors and metastasis are excluded) Participants aged between 20-80 No precipitating or previous disease or condition, as MS or Guillain-Barre,..... Pain score more than 4 according to NRS schedule Pain course more than 3 months LBP with radiation to below the knee, leg pain more severe than LBP

Exclusion criteria

Exclusion criteria: Patients with cognitive disorders even with minor signs and symptoms and also patients with rheumatologic, neurologic, and any infectious disease like brucellosis. Patients with previous or current consumption of statins. Patients consuming Imidazoles, cimetidine, Amiodarone, sulfine pyrasone would be excluded for the possible interaction with rosuvastatin.

Design outcomes

Primary

MeasureTime frame
Chronic pain score. Timepoint: before intervention, 2, 4 weeks after intervention. Method of measurement: Numerical Rating Scale (NRS) and Douleur Neuropathic (DN4) questionnaire.

Secondary

MeasureTime frame
Quality of life. Timepoint: before intervention and 4 weeks after beginning the treatment. Method of measurement: Short-form 36 (SF36) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSasan Gazerani

Saveh University of Medical Sciences

s_gazerani@hotmail.com+98 86 4234 3395

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026